CA3128232A1 - Enhanced nitrate compositions and methods of use - Google Patents

Enhanced nitrate compositions and methods of use Download PDF

Info

Publication number
CA3128232A1
CA3128232A1 CA3128232A CA3128232A CA3128232A1 CA 3128232 A1 CA3128232 A1 CA 3128232A1 CA 3128232 A CA3128232 A CA 3128232A CA 3128232 A CA3128232 A CA 3128232A CA 3128232 A1 CA3128232 A1 CA 3128232A1
Authority
CA
Canada
Prior art keywords
elemental
nitrate anion
composition
nitrate
source
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3128232A
Other languages
English (en)
French (fr)
Inventor
Alexandros Nikolaidis
Ronald Kramer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thermolife International LLC
Original Assignee
Thermolife International LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thermolife International LLC filed Critical Thermolife International LLC
Publication of CA3128232A1 publication Critical patent/CA3128232A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Catalysts (AREA)
CA3128232A 2019-02-01 2020-01-31 Enhanced nitrate compositions and methods of use Pending CA3128232A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962800361P 2019-02-01 2019-02-01
US62/800,361 2019-02-01
US201962866540P 2019-06-25 2019-06-25
US62/866,540 2019-06-25
US16/779,349 2020-01-31
PCT/US2020/016274 WO2020160509A1 (en) 2019-02-01 2020-01-31 Enhanced nitrate compositions and methods of use
US16/779,349 US20200222449A1 (en) 2019-02-01 2020-01-31 Enhanced Nitrate Compositions and Methods of Use

Publications (1)

Publication Number Publication Date
CA3128232A1 true CA3128232A1 (en) 2020-08-06

Family

ID=71517286

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3128232A Pending CA3128232A1 (en) 2019-02-01 2020-01-31 Enhanced nitrate compositions and methods of use

Country Status (12)

Country Link
US (5) US20200222449A1 (https=)
EP (1) EP3917543A4 (https=)
JP (1) JP7534310B2 (https=)
KR (1) KR102789451B1 (https=)
CN (1) CN113498345A (https=)
AU (2) AU2020215729B2 (https=)
BR (1) BR112021015110A2 (https=)
CA (1) CA3128232A1 (https=)
EA (1) EA202192132A1 (https=)
IL (1) IL285247A (https=)
MX (1) MX2021009287A (https=)
WO (1) WO2020160509A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8466187B2 (en) 2007-09-18 2013-06-18 Thermolife International, Llc Amino acid compositions
US12612370B2 (en) 2011-03-02 2026-04-28 Thermolife International, Llc Amino acid compositions
WO2022192743A1 (en) * 2021-03-11 2022-09-15 Thermolife International, Llc Enhanced nitrate, elemental metal, and amino acid compositions and methods of use
US11865139B2 (en) 2020-11-12 2024-01-09 Thermolife International, Llc Method of treating migraines and headaches
WO2022174116A1 (en) * 2021-02-11 2022-08-18 Thermolife International, Llc A method of administering nitric oxide gas
JP2024541338A (ja) * 2020-11-12 2024-11-08 サーモライフ インターナショナル， エルエルシー 血中酸素飽和度を増大させる方法
AU2022220004A1 (en) * 2021-02-11 2023-08-17 Thermolife International, Llc A method of administering nitric oxide gas
JP2024508952A (ja) * 2021-03-11 2024-02-28 サーモライフ インターナショナル， エルエルシー ニトレートと単体金属とアミノ酸との増強された組成物ならびに使用方法
CA3226249A1 (en) * 2021-08-16 2023-02-23 Thermolife International, Llc Iron supplement compositions and methods of use thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU476799B2 (en) * 1974-02-04 1976-08-05 Carlton And United Breweries Limited Preparation of a water soluble isomerised hop extract
US6703056B2 (en) * 2000-09-29 2004-03-09 The Procter + Gamble Co. Beverage compositions comprising arabinogalactan and defined minerals
US7208170B2 (en) * 2002-09-20 2007-04-24 Petersson Lennart G Powder teat dip germicide, fungicide and skin conditioner
CN100399948C (zh) * 2002-12-06 2008-07-09 协和发酵工业株式会社 含氨基酸的饮料和减少氨基酸苦味的方法
DK2124638T3 (en) 2007-02-26 2017-03-20 Heartbeet Ltd COMPOSITION INCREASING PERFORMANCE AND USING IT
US10646508B1 (en) * 2007-09-18 2020-05-12 Thermolife International, Llc Method of safely administering nitrate dietary supplements and compositions
US7777074B2 (en) 2007-09-18 2010-08-17 Thermolife International, Llc Amino acid compounds
US20110123654A1 (en) * 2008-06-06 2011-05-26 Ralf Jaeger Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon
US8303995B1 (en) * 2008-06-13 2012-11-06 Board Of Regents, The University Of Texas System Nitrite formulations and their use as nitric oxide prodrugs
ES2538652T3 (es) 2009-06-16 2015-06-23 Dusan Miljkovic Composiciones y procedimientos para producir un potencial negativo de oxidación-reducción estable en materiales consumibles
JP2014513527A (ja) 2011-04-21 2014-06-05 ネステク ソシエテ アノニム パフォーマンス向上のための栄養組成物並びにその作製及び使用方法
JP6016610B2 (ja) 2012-12-20 2016-10-26 江崎グリコ株式会社 筋肉増量用サプリメント
CA2965441C (en) * 2014-10-22 2020-03-24 Innoveco Australia Pty. Ltd. Process for metal extraction with sorption leaching in wet solids
ES2651717B1 (es) 2016-07-26 2018-11-16 Lara OLLER DUQUE Solución acuosa cristaloide isotónica
US10624921B2 (en) * 2016-11-15 2020-04-21 Berkeley Nox Limited Dietary supplements
WO2020214841A1 (en) * 2019-04-16 2020-10-22 Thermolife International, Llc Hexylamine salts and methods of using hexylamine

Also Published As

Publication number Publication date
AU2020215729B2 (en) 2023-03-30
JP2022523513A (ja) 2022-04-25
EP3917543A4 (en) 2022-10-12
KR102789451B1 (ko) 2025-03-31
KR20210119499A (ko) 2021-10-05
US20200222449A1 (en) 2020-07-16
US20240122967A1 (en) 2024-04-18
EA202192132A1 (ru) 2021-10-19
AU2020215729A1 (en) 2021-09-02
AU2023203649B2 (en) 2024-11-14
WO2020160509A1 (en) 2020-08-06
EP3917543A1 (en) 2021-12-08
US20240122968A1 (en) 2024-04-18
US20240122966A1 (en) 2024-04-18
US20240122969A1 (en) 2024-04-18
MX2021009287A (es) 2021-11-12
CN113498345A (zh) 2021-10-12
AU2023203649A1 (en) 2023-07-06
JP7534310B2 (ja) 2024-08-14
BR112021015110A2 (pt) 2022-01-11
IL285247A (en) 2021-09-30

Similar Documents

Publication Publication Date Title
AU2023203649B2 (en) Enhanced nitrate compositions and methods of use
AU784752B2 (en) Food supplement for increasing lean mass and strength
CN102018832B (zh) 一种用于减肥的组合物及其制备方法
RU2492705C2 (ru) ПИЩЕВАЯ ДОБАВКА, СОДЕРЖАЩАЯ α-КЕТОКИСЛОТЫ
EP3294281A1 (en) Amino acid supplementation
CN105533213A (zh) 一种维生素矿物质营养膏及其制备方法
CN102048884B (zh) 一种含瓜拉那提取物的减肥组合物
WO2009082883A1 (fr) Composition anti-obésité
CN102150838A (zh) 一种减肥组合物，包含组合物的制剂及其制备方法
CN101331950A (zh) 一种提高运动爆发力的营养补剂
CN112690457A (zh) 一种用于超重和肥胖人群的营养素组合物配方
EA049159B1 (ru) Улучшенный нитратный состав и способы применения
CN115137066A (zh) 一种减肥片剂及其制备方法
CN116138450A (zh) 一种含5-氨基乙酰丙酸或其衍生物的运动营养组合物及制备方法和应用
US20250000832A1 (en) Enhanced nitrate, elemental metal, and amino acid compositions and methods of use
CN115868628B (zh) 减肥组合物
US20240341342A1 (en) High efficancy hydration composion, production method, and use.
US20220387482A1 (en) Performance enhancement delivery system
CN119856781A (zh) 一种抗衰的运动营养食品制备方法
US20250082580A1 (en) Controlled-release oral formulation and preparation method thereof
RU2741079C1 (ru) Пищевая добавка «пребио дкв»
CN120753397A (zh) 一种新型营养组合物及其应用
CN107875170B (zh) 一种含有碳酸钙的泡腾剂
WO2023272693A1 (zh) 一种维生素c加硫酸亚铁缓控释片及其制备方法
CN115721018A (zh) 一种增强耐力的组合物

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20221220

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D120 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: VOLUNTARY SUBMISSION OF PRIOR ART RECEIVED

Effective date: 20240814

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION

Effective date: 20240814

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250124

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250124

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250124

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250213

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D00-D123 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: PRIOR ART DISCLOSURE DETERMINED COMPLIANT

Effective date: 20250410

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250410

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250415

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250415